Laboratory Corporation of America has launched InformaSeq, a noninvasive prenatal test that screens for fetal aneuploidies in chromosomes 21, 18, and 13, with the option of also screening for some common sex-related aneuploidies. The test will run on an Illumina next-gen sequencing system.
New Products: LabCorp's InformaSeq
Premium